my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Introduction
In 2010, Datamonitor estimates that there were 7.4 million major abdominal surgeries in the seven major markets. This number is not expected to change significantly, growing to 8.1 million surgeries in 2020.
Features and benefits
* Gain insight to market potential, including a robust 10-year epidemiology forecast of major abdominal surgeries.
* Understand the key epidemiologic risk factors associated with major abdominal surgery and how it is related to deep vein thrombosis.
Highlights
Datamonitor’s epidemiologists expect to see a small increase in the number of major abdominal surgeries between 2010 and 2020 in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK). The number of abdominal surgeries is expected to increase from around 7,436,000 surgeries in 2010 to 8,109,000 surgeries in 2020.
In 2010, Datamonitor expects that the number of abdominal surgeries will differ significantly by age group. In the seven major markets, there will be approximately 166,400 surgeries in those under 15, 5,125,000 in those between 15 and 44, 1,194,000 in those between 45 and 64, and 950,300 surgeries in those over the age of 65.
The most commonly performed major abdominal surgery is Cesarean section in all seven major markets. It is estimated that Cesarean sections make up approximately one third of all major abdominal surgeries.
Your key questions answered
* What are the most robust sources for major abdominal surgery data?
* How will the patient population change over the next decade in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK)?
* How do changes in population structure and risk factors affect the trend in number of major abdominal surgeries?
| Pharmacy / Drugs | Market study | |
|---|---|---|
| Year: | 2011 | |
| Publisher: | Datamonitor plc | |
| Price: | 5,700.00€ |
Order market study
Order the market study at markt-studie.de
Watchlist
This is where you can add this market study to your personal favourites.
Introduction Global Leisure Products industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics ... more
Introduction Global Leisure Facilities industry profile provides top-line qualitative and quantitative summary information including: market size (value , and forecast to 5). The profile also contains descriptions of the leading players including key financial metrics and analysis of compe ... more
Introduction In 2010, Datamonitor estimates that there were 7.4 million major abdominal surgeries in the seven major markets. This number is not expected to change significantly, growing to 8.1 million surgeries in 2020. Features and benefits * Gain insight to market potential, including ... more
Australia’s Top 20 cancer drugs to reach sales of $1 billion by 2018
The Australian oncology market’s high value and growth opportunities have made it an attractive arena for drug developers to enter. Top 20 cancer therapy brands sales totaled $545m in Australia in 2008, growing at a CAGR of 30% since 2005. Although this growth is expected to slow down consi ... more
Obesity and type 2 diabetes market closely linked but vastly different in outlook
The independent business analyst forecasts that the antidiabetics market will be worth $37 billion by 2018 up from $20 billion in 2008. This rapid market expansion presents significant opportunities for pharmaceutical companies who are able to develop new therapies to address the unmet clin ... more
Big pharmaceutical struggles to benefit from increased CVD drug usage
Pharmaceutical companies will struggle to profit from the cardiovascular disease (CVD) market over the next decade despite growing drug usage, according to Datamonitor. New research by the independent business analyst predicts that the CVD pharma market will grow from $99bn in 2008 to $107b ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
